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Fig 1. Chronic recurrent multifocal osteomyelitis.
Onycholysis, nail pits, oil spots, and discoloration of the
nails as well as erythema, hyperkeratosis, pustules on the
sole of our 9-year-old female patient.
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To the Editor: A 9-year-old girl presented with a
15-month history of severe joint pain limited to the
right ankle. She had been treated for fatigue
fracture and epiphysitis, but continued to require
the use of crutches. The patient had pronounced
muscular atrophy of the right leg, swelling and
hyperthermia at the heel, and plantar pustulosis.
She had mild paronychia on most fingers of the right
hand and progressive changes in the fingernails,
which were characteristic of nail psoriasis (Fig 1).
Thus, psoriatic arthritis or osteitis was suspected, and
oral naproxen (200 mg twice daily) therapy was
prescribed. Whole-body magnetic resonance
imaging (MRI) was performed and demonstrated
inflammatory bone lesions, osteolysis, and sclerotic
lesions (Fig 2). Laboratory parameters were within
normal ranges. Her family history was unremarkable
for similar cutaneous or musculoskeletal pathology.
Chronic recurrent multifocal osteomyelitis (CRMO)
with multifocal bone lesions, plantar pustulosis, and
nail involvement was diagnosed. Oral methotrexate
therapy (15 mg/week) was initiated and naproxen
was continued. After 6 months, the joint pain
resolved, and muscular atrophy, palmar pustulosis,
and nail lesions improved.
CRMO is an acquired aseptic autoinflammatory
bone disease that presents predominantly in girls
and is characterized by pain that is worse at
night, with or without fever. Typically there is a
discrepancy between the mild symptoms and
extensive bone inflammation. Sedimentation rate
and C-reactive protein (CRP) valuesmay be elevated,Open access under CC BY-NC-ND license.while the white blood cell count and other
laboratory parameters are usually normal. The
diagnosis of CRMO is mainly reliant on imaging
studies. Conventional radiography initially shows
osteolytic bone lesions with development of
peripheral sclerosis in the course of the disease.
MRI may show early lesions such as edema of
bone marrow and inflammation of soft tissue. In
order to diagnose CRMO, two major or one major
and three minor criteria must be fulfilled.1-3 Major
criteria are osteolytic or sclerotic bone lesions,
multifocal bone lesions, palmoplantar pustulosis or
psoriasis, and sterile bone biopsy with signs of
inflammation, fibrosis, or both. Minor criteria are
normal blood cell count, good general health,
slightly to moderately elevated CRP and erythrocyte
sedimentation rate, clinical course of at least 6
months, hyperostosis, association with autoinflam-
matory diseases other than palmoplantar pustulosis
or psoriasis, and a first- or second-degree relative
with nonbacterial osteitis, or autoimmune or auto-
inflammatory disorders.
Some authors believe CRMO to be a juvenile
variant of the SAPHO syndrome (synovitis, acne,
pustulosis, hyperostosis, osteitis). However, to
what extent CRMO and SAPHO present a spectrum
of one disease or separate entities remains
controversial.2
There is no standard therapy of CRMO; however,
nonsteroidal antiinflammatory drugs (NSAIDs) are
considered to be first-line treatment with a favorable
response rate in up to 80% of patients. Patients
may require therapy to control skin and bone
lesions, and NSAIDs can be used during attacks or
to prevent attacks.5 NSAID therapy is usually
continued until patients are symptom-free for at least
3 months. When NSAID therapy is inadequate,
primary treatment options are bisphosphonates and
tumor necrosis factor antagonists,5 and strong data
Fig 2. Chronic recurrent multifocal osteomyelitis. Whole-body magnetic resonance imaging
detecting inflammatory bone lesions, osteolyses, and scleroses most prominent in the left
shoulder, the right foot, and both elbows and ankles.
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corticosteroids, methotrexate, sulfasalazine, azathio-
prine, and colchicine.3-5 Spontaneous remission is
possible; however, CRMO is a disorder that resolves
after many years with episodes of remission and
relapse, most often without permanent sequelae.
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Are arteriovenous malformations a causative
factor for hypertrophic and nodular port-wine
stains?
To the Editor: Arteriovenous malformation (AVM), a
vascular hamartomatous malformation, is rarely
found on biopsy of hypertrophic and nodular
port-wine stains (PWS).1,2 Digital subtraction
angiography (DSA) is the gold standard method for
